Dovato is available as a tablet. The pill size of Dovato is not specified in the provided information.
What does Dovato treat?
Dovato is a prescription medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults. It is indicated for patients who have not previously taken any HIV-1 medicines [1].
How does Dovato work?
Dovato is a combination of two antiretroviral medications, dolutegravir and lamivudine. It works by decreasing the amount of HIV in the body, which is called the viral load. Having a lower viral load helps the immune system to work better and reduces the risk of HIV transmission to others [1].
What are the side effects of Dovato?
Common side effects of Dovato can include headache, nausea, diarrhea, fatigue, trouble sleeping, dizziness, and rash [1]. Serious side effects may include allergic reactions, liver problems, lactic acidosis, and worsening of hepatitis B infection if you have it [1].
How is Dovato prescribed?
Dovato is taken by mouth once a day [1].
When does Dovato patent expire?
Information on Dovato's patent expiry is not available in the provided context. DrugPatentWatch.com tracks drug patents and their expiration dates, which could be a resource for this information [2].